Patents Assigned to The General Hospital Corporation d/b/a Massachussetts General Hospital
  • COMPOSITIONS AND METHODS FOR MODULATING UTRN EXPRESSION
    Publication number: 20150099791
    Abstract: Aspects of the invention provide single stranded oligonucleotides for activating or enhancing expression of UTRN. Further aspects provide compositions and kits comprising single stranded oligonucleotides for activating or enhancing expression of UTRN. Methods for modulating expression of UTRN using the single stranded oligonucleotides are also provided. Further aspects of the invention provide methods for selecting a candidate oligonucleotide for activating or enhancing expression of UTRN.
    Type: Application
    Filed: May 16, 2013
    Publication date: April 9, 2015
    Applicants: RaNA Therapeutics, Inc., The General Hospital Corporation d/b/a Massachussetts General Hospital
    Inventors: Arthur M. Krieg, Romesh Subramanian, James McSwiggen, Jeannie T. Lee